A detailed history of Bfsg, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bfsg, LLC holds 467 shares of ABT stock, worth $53,345. This represents 0.01% of its overall portfolio holdings.

Number of Shares
467
Previous 467 -0.0%
Holding current value
$53,345
Previous $48,000 10.42%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$100.73 - $112.44 $10,073 - $11,244
-100 Reduced 17.64%
467 $48,000
Q1 2024

Apr 23, 2024

BUY
$109.52 - $120.96 $10,952 - $12,096
100 Added 21.41%
567 $64,000
Q4 2023

Feb 01, 2024

BUY
$90.19 - $110.4 $42,118 - $51,556
467 New
467 $51,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bfsg, LLC Portfolio

Follow Bfsg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.